# Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

> **NCT01982916** · PHASE3 · COMPLETED · sponsor: **Ahn-Gook Pharmaceuticals Co.,Ltd** · enrollment: 324 (actual)

## Conditions studied

- Allergic Rhinitis
- Perennial Allergic Rhinitis
- Non-seasonal Allergic Rhinitis

## Interventions

- **DRUG:** AGR tablet
- **DRUG:** Placebo (for AGR tablet and/or Active Comparator)
- **DRUG:** Active Comparator

## Key facts

- **NCT ID:** NCT01982916
- **Lead sponsor:** Ahn-Gook Pharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2018-03-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01982916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01982916, "Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01982916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*